COMP <GO>
BN vs CVSA // REVENUE GROWTH (YOY)
Brookfield Corporation Class A Limited Voting Shares (NYSE) VS. Covista Inc. (NYSE) • 15-METRIC TALLY: BN 3
— CVSA 11
▲ REVENUE GROWTH (YOY) LEADER: CVSA
LAST: $39.28 (-0.56%) • MKT CAP: $96.80B
revenue-growth
-1.10%
LAST: $124.33 (-3.44%) • MKT CAP: $4.36B
revenue-growth
12.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BN VS. CVSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BN | CVSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 56.90% | -15.90 | CVSA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 14.80% | -4.90 | CVSA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 12.5x | +8.50 | CVSA | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 6.60% | -4.39 | CVSA | /fcf-yield <GO> |
| Operating Margin | 13.90% | 19.10% | -5.20 | CVSA | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 13.30% | -2.40 | CVSA | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -1.10% | 12.90% | -14.00 | CVSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 3.40% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 4.73 | -0.99 | CVSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | CVSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.10% | -0.60 | BN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 43.0 | +20.61 | BN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.05 | -0.17 | CVSA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 15.5x | +15.00 | CVSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $96.80B | $4.36B | $92.44B | BN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BN REV | CVSA REV | BN GROSS % | CVSA GROSS % | BN FCF | CVSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $1.79B | — | 56.9% | — | $287.6M |
| FY 2024 | — | $1.58B | — | 55.9% | — | $246.9M |
| FY 2023 | — | $1.45B | — | 44.0% | — | $126.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BN // BETA 0.88
CVSA // BETA 1.05